Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • DRUGS AND BIOLOGICS—U.S.: Supreme Court maintains status quo on mifepristone access pending appeal
    • ADMINISTRATION OF FDC ACT—NOTICES: FDA issues annual compilation of STIC web page updates
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—CMS LETTERS: CMS adds new stratification standards to FFY 2027 Core Sets
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—GAO REPORTS: CRA applies to WISeR Model Notice
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—PRRB DECISIONS: Contractor incorrectly disallowed half-million-dollar bad debt reimbursement to Indiana hospital
    • EXPERT INSIGHTS—Government Contractors, Take Note: Illinois Court Curtails Broad BIPA Exemption
    • FOOD—N.D. Ill.: General causation expert could testify in infant formula dispute where intervening cause arguments did not warrant exclusion
    • GENERAL HEALTH CARE NEWS—CBO REPORTS: CBO releases a report with baseline projections for federal spending on health insurance subsidies from 2026 to 2036
    • MEDICAID—NOTICES: CMS reopens comment period on Medicaid, CHIP data collection after eligibility template error
    • PROGRAM INTEGRITY—NOTICES: CMS imposes nationwide hospice and home health enrollment moratoria as part of antifraud crackdown
    • TOBACCO—FDA GUIDANCE NOTICES: FDA issues final guidance on enforcement priorities for unauthorized tobacco products
    • VETERINARY DRUGS—S.D. Cal.: Horse ointment users’ reproductive injury claims survive motion to strike fraud allegations and request for definite statement
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, TOBACCO—FDA GUIDANCE NOTICES: FDA issues final guidance on enforcement priorities for unauthorized tobacco products, (May 15, 2026)

    By WK Editorial Staff

    The final guidance outlines enforcement priorities for certain unauthorized electronic nicotine delivery systems and oral nicotine pouch products.

    The Food and Drug Administration announced the availability of a final guidance outlining its enforcemen ...

    By WK Editorial Staff

    The final guidance outlines enforcement priorities for certain unauthorized electronic nicotine delivery systems and oral nicotine pouch products.

    The Food and Drug Administration announced the availability of a final guidance outlining its enforcement priorities for certain new tobacco products marketed without required premarket authorization. The guidance focuses on electronic nicotine delivery systems and oral nicotine pouch products that are currently being sold without FDA authorization, which are considered illegally marketed. It is intended to promote transparency and help the agency allocate enforcement resources toward products that are more likely to meet public health standards. The approach is designed to encourage the development and submission of applications for potentially less harmful products while supporting a transition to a more regulated, compliant marketplace (Notice, 91 Fed. Reg. 25892 (May 12, 2026)).

    Dates. The announcement of the guidance is published in the Federal Register on May 12, 2026.

    FederalRegisterIssuances: FDAGuidanceNotices FDCActNews TobaccoNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use